Chimerix, Inc.
CMRX
$8.52
$0.010.12%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/9/2025
-
Zacks Investment Research
4/9/2025
-
MarketBeat
4/8/2025
-
MarketBeat
4/4/2025
-
MarketBeat
4/3/2025
-
MarketBeat
4/1/2025
-
Yahoo! Finance: News
4/1/2025
-
Insider Monkey
3/31/2025
-
Insider Monkey
3/31/2025
-
MarketBeat
3/31/2025
-
MarketBeat
3/26/2025
-
MarketBeat
3/26/2025
-
Insider Monkey
3/25/2025
-
Ticker Report
3/25/2025
-
TipRanks Financial Blog
3/25/2025
-
Insider Monkey
3/23/2025
-
MarketBeat
3/23/2025
-
MarketBeat
3/22/2025
-
MarketBeat
3/22/2025
-
Ticker Report
3/22/2025
-
Tickeron - Stocks
3/21/2025
-
FierceBiotech.com - Biotech
3/21/2025
-
GuruFocus
3/21/2025
-
GuruFocus
3/21/2025
-
The Fly
3/21/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, March 21, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
919 806 1074
Address
2505 Meridian Parkway
Durham, NC 27713
Durham, NC 27713
Country
Year Founded
Business Description
Sector
Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline products include ONC201 a program that is in Phase...
more
